Related Experiment Video
Updated: May 29, 2026

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
Published on: June 7, 2024
Decoding the microbiome-immune crosstalk in cancer: from mechanisms to therapeutic translation
Ning Zhao1,2, Liang Wu3, Sha Peng1
1Department of Surgical Oncology, First Affiliated Hospital of Xi'an JiaoTong University, Xi'an, 710061, China.
Abstract:
The gut microbiome plays a critical role in shaping host immunity and profoundly affects the efficacy of cancer immunotherapy. Accumulating evidence suggests that interventions designed to alter the microbial community, including fecal microbiota transplantation, probiotics, and engineered bacteria, can reprogram the tumor-immune microenvironment and enhance clinical efficacy. This Review provides a comprehensive overview of the molecular and cellular mechanisms through which the gut microbiota influences antitumor immunity, and it highlights recent clinical studies evaluating these interventions. We further examine inherent challenges, including inter-individual variability in microbial composition, difficulties in achieving stable and durable colonization, technical barriers in delivery, and potential safety concerns associated with immune activation or off-target effects. Finally, we discuss future directions for translating microbiome-targeted therapies into oncology, emphasizing the need for mechanistic insight, standardized protocols, rigorous evaluation, and integration with precision immunotherapy strategies to optimize therapeutic outcomes.
Insights
The gut microbiome significantly impacts cancer immunotherapy effectiveness. Modifying gut bacteria shows promise for enhancing antitumor immunity and treatment outcomes, despite challenges.
Area of Science:
- Oncology
- Immunology
- Microbiology
Background:
- The gut microbiome is crucial for host immunity and cancer immunotherapy efficacy.
- Microbial alterations can reprogram the tumor-immune microenvironment.
Purpose of the Study:
- To provide a comprehensive overview of gut microbiota's influence on antitumor immunity.
- To highlight clinical studies on microbiome-targeted cancer therapies.
- To examine challenges and future directions in the field.
Main Methods:
- Review of molecular and cellular mechanisms.
- Analysis of recent clinical studies.
- Examination of challenges and future directions.
Main Results:
- Gut microbiota influences antitumor immunity through various mechanisms.
- Microbiome interventions like FMT and probiotics show potential in enhancing immunotherapy.
- Challenges include variability, colonization, delivery, and safety.
Conclusions:
- Microbiome-targeted therapies offer a promising avenue for improving cancer immunotherapy.
- Further research is needed for mechanistic insight, standardization, and integration with precision medicine.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Psychoneuroimmunology: Diabetes and Cancer
The Tumor Microenvironment
